ArticleFuture oncology (London, England)2024

The application of QCT in the prognostic assessment of mCRC undergoing first-line treatment based on bevacizumab.

Xudong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.